Form SC 13G/A Hims & Hers Health, Inc. Filed by: VANGUARD GROUP INC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Hims and Hers (HIMS) PT Raised to $24 at Citi
November 5, 2024 6:31 AM ESTCiti analyst Daniel Grosslight raised the price target on Hims and Hers (NYSE: HIMS) to $24.00 (from $20.00) while maintaining a Neutral rating.
The analyst comments "HIMS results continue to impress, with another significant beat-and-raise across the board (LINK). Given much of this outperformance was... More



